SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hollis Eden Pharmaceuticals Inc. (HEPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biojunkie who wrote (32)3/19/1998 7:22:00 PM
From: BDR  Read Replies (1) of 138
 
<<Thanks for providing us with your insight and understanding of
bioavailability (how much drug gets into the bloodstream)with regards to
the hormone which you've mentioned is available at your corner
drug/healthfood store. >>

I did? All I offered were quotes from the company's own material. I don't recall providing bioavailability data.

<<Wouldn't it be a shame if you shorted a company that may have a less expensive,
easier to use drug that dramatically inhibits HIV replication?>>

It would be, but do you have references to support that claim for the drug?

(Jumper- we won't need your services. A real long has surfaced.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News